Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity

Immunology

Volumn 103, Issue 4, 2001, Pages 449-457

  Seo, Naohiro ^a   Hayakawa, Satoshi ^b   Takigawa, Masahiro ^a   Tokura, Yoshiki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL LINE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENETIC ASSOCIATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TH1 CELL; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INTERLEUKIN-10; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034880059     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01279.x     Document Type: Article

References (37)

1. The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects
2. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice
3. Early-appearing tumor-infiltrating natural killer cells play an important role in the nitric oxide production of tumor-associated macrophages through their interferon production
4. In vivo priming of two distinct antitumor effector populations: The role of MHC class I expression
5. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice
6. TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice
7. Regulatory mechanisms for production of 1FN-γ, and TNF by antitumor T cells or macrophages in the tumor-bearing state
8. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients
9. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10
10. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis
11. Transforming growth factor-β-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state
12. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4 (+) T cells
13. + T cells subset inhibits antigen-specific T cell responses and prevents colitis
14. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
15. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis
16. Infectious tolerance
17. IL-4 and IL-10 are both required for the induction of oral tolerance
18. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles
19. Immunotherapy with low-dose interleukin-2 and anti-transforming growth factor-β antibody in a murine tumor model
20. Effects of anti-transforming growth factor-β antibody and interleukin-2 in tumor-bearing mice
21. Effect of advanced ageing on ability of mice to cause regression of an immunogenic lymphoma in response to immunotherapy based on depletion of suppressor T cells
22. Suppression of cytotoxic T lymphocyte activity by γ/δ T cells in tumor-bearing mice
23. b molecules expressed on Th2-type γδ T and αβ T cells co-infiltrating in early B16 melanoma lesions
24. Depletion of IL-10-and TGF-β-producing regulatory γδ T cells by administered a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells
25. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented With granulocyte/macrophage colony-stimulating factor
26. + murine hematopoietic progenitor cells
27. + T cells and induces the synthesis of IL-3 and IFN-γ but not IL-4 or IL-6
28. Identification and induction of keratinocyte-derived IL-10
29. Local cytokine production in a murine model of Escherichia coli pyelonephritis
30. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody
31. Down-regulation of innate and acquired anti-tumor immunity by bystander γδ and αβ T lymphocytes with Th2 or Tr1 cytokine profiles
32. The cytokine stew and innate resistance to L. monocytogenes
33. Regulation of immune responses by TGF-β
34. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo
35. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
36. Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method
37. Tumor antigens recognized by T lymphocytes